Department of Chemistry "Ugo Schiff", University of Florence , Florence , Italy.
J Enzyme Inhib Med Chem. 2013 Oct;28(5):936-43. doi: 10.3109/14756366.2012.696245. Epub 2012 Jul 18.
The analysis of the structural similarity between Candida albicans Sap2 and HIV-1 aspartic proteases by molecular modeling gave insight into the common requirements for inhibition of both targets. Structure superimposition of Sap2 and HIV-1 protease confirmed the similarity between their active sites and flap regions. HIV-1 protease inhibitors herein investigated can fit the active site of Sap2, adopting very similar ligand-backbone conformations. In particular, key anchoring sites consisting of Gly85 in Sap2 and Ile50 in HIV-1 protease, both belonging to their corresponding flap regions, were found as elements of a similar binding-mode interaction. The knowledge of the molecular basis for binding to both Sap2 and HIV-1 proteases may ultimately lead to the development of single inhibitor acting on both targets.
通过分子建模分析白色念珠菌 Sap2 和 HIV-1 天冬氨酸蛋白酶之间的结构相似性,深入了解了抑制这两个靶点的共同要求。Sap2 和 HIV-1 蛋白酶的结构叠加证实了它们活性位点和瓣区之间的相似性。本文研究的 HIV-1 蛋白酶抑制剂可以适应 Sap2 的活性位点,采用非常相似的配体-骨架构象。特别是,由 Sap2 中的 Gly85 和 HIV-1 蛋白酶中的 Ile50 组成的关键锚定点,都属于它们相应的瓣区,被发现是类似结合模式相互作用的元素。对 Sap2 和 HIV-1 蛋白酶结合的分子基础的了解,最终可能导致开发出同时作用于这两个靶点的单一抑制剂。